Drugs and other treatments can be quite effective at killing cancer cells, yet many fall short as they struggle to penetrate ...

Imagine if a doctor could remotely do a non-invasive, highly precise medical procedure on her patients using a tiny robot, or ...

Magnet Biomedicine announced Friday it has reached a licensing agreement worth up to $1.25B with Eli Lilly (NYSE:LLY) to develop cancer drugs leveraging the company’s TrueGlue discovery platform.